Zimmer Biomet holds the cleaner structural position, with the lead spread across growth and stability. Elanco Animal Health still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Elanco Animal Health carries the stronger setup — intact trend against Zimmer Biomet's broken trend. That leaves a split case: the structural lead stays with Zimmer Biomet, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The clearest separation starts in growth, but stability adds another real layer to the result. The overall score gap is 19 points in favour of Zimmer Biomet Holdings, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
Most of the shared profile comes through margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Zimmer Biomet Holdings, Inc. looks stronger both structurally and on relative valuation.
Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.
Where ELAN and ZBH each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Earnings growth is one contributing factor within the growth lead.
On the market side, Elanco Animal Health carries the stronger trend while Zimmer Biomet's trend has broken — the market setup does not confirm the structural advantage.
The lead is built on both growth and stability — though valuation still provides a counterweight.
Break down the ELAN vs ZBH comparison across all dimensions with the full interactive tool.
Explore how ELAN and ZBH each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.